does semaglutide cause kidney issues in Diabetic Disease: Integrating Clinical Evidence with Mechanistic Insights Semaglutide and Urinary Tract Infections:

Tirzepatide does not come in a one-size-fits-all format

Studies have demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with research subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles

It did say that revenue from non-GLP-1 drugs was $1.2 billion of the $1.4 billion it brought in 2024, suggesting it sold roughly $200 million in copycat weight-loss drugs last year.

Average weight loss was 11.4 pounds for Noom Med and 3.3 pounds for Noom Healthy Weight

GLP-1s for Psoriatic Arthritis (PsA) Asthma One study of more than 3,000 adults who were overweight or had obesity found that those taking a GLP-1 had a 12 to 15 percent lower risk of asthma exacerbations than those not taking these drugs